Towards Clinical Translation of Penetrating Multisite Device for Cochlear Nucleus

Information

  • Research Project
  • 9232137
  • ApplicationId
    9232137
  • Core Project Number
    R01DC014044
  • Full Project Number
    7R01DC014044-03
  • Serial Number
    014044
  • FOA Number
    PAR-14-009
  • Sub Project Id
  • Project Start Date
    3/19/2015 - 9 years ago
  • Project End Date
    2/29/2020 - 4 years ago
  • Program Officer Name
    MILLER, ROGER
  • Budget Start Date
    3/1/2017 - 7 years ago
  • Budget End Date
    2/28/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    03
  • Suffix
  • Award Notice Date
    5/18/2017 - 7 years ago

Towards Clinical Translation of Penetrating Multisite Device for Cochlear Nucleus

? DESCRIPTION (provided by applicant): Patients with severely damaged auditory nerves cannot benefit from cochlear implants. The goal of this project is to accelerate the translation of silicon-based, multisite, penetrating microelectrode arrays to a cochlear nucleus auditory prosthesis. We have recently made significant technological advances with our devices in the cat model, which together with high-count cables and feedthroughs will provide a unique opportunity to develop arrays of multisite microelectrodes that are suitable for clinical use. This project will demonstrate the feasibility of interfacing a multisite microelectrode array with a lare number of microstimualting sites to an implantable pulse generator (IPG), in preparation for a subsequent clinical trial. Validation of the cochlear nucleus implant for clinical use will also advance other configurations of silicon- substrate multisite microelectrode arrays toward clinical use. These include the auditory nerve and the auditory midbrain (inferior colliculus), and perhaps even the primary auditory cortex. We are proposing to conduct appropriate tests under two ISO (International Organization for Standardization) guidelines: (1) ISO 10933 in Aim 1 to validate the biocompatibility of the electrode array and associated cables, and (2) ISO 14708 in Aim 2 for interfacing the array and cable to a neurostimulator. In Aim 2, we will develop the interface to an IPG, and determine the compliance of the system in-vitro per ISO 14708 which specifies requirements for reliable interfaces to neurostimulators. These tests are a critical majo step to optimizing our devices for a future investigational device exemption by the FDA. The successful outcome of the project will be the translation of a new generation of multisite, penetrating silicon microelectrode arrays that will be implanted in a human cochlear nucleus, allowing for unprecedented access to the tonotopic organization of the nucleus. Finally, these multisite silicon devices can be modified for other neurological conditions including spinal cord and deep brain stimulation.

IC Name
NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
  • Activity
    R01
  • Administering IC
    DC
  • Application Type
    7
  • Direct Cost Amount
    225000
  • Indirect Cost Amount
    109782
  • Total Cost
    334782
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    173
  • Ed Inst. Type
  • Funding ICs
    NIDCD:334782\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZDC1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF CONNECTICUT
  • Organization Department
  • Organization DUNS
  • Organization City
    STORRS
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    06268
  • Organization District
    UNITED STATES